+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Palatin Technologies Inc - logo

Palatin Technologies is a biopharmaceutical company that develops targeted, receptor-specific peptide therapeutics for the treatment of various diseases in the United States. The company’s leading product is Bremelanotide, which is used to treat hypoactive sexual desire disorder (HSDD). It has completed pivotal Phase 3 clinical trials. Palatin also has development programs or drug candidates for inflammatory disease indications, heart failure and fibrosis. It was founded in 1986 and is based in Cranbury, New Jersey.

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025 - Product Thumbnail Image

Distribution Deals in Pharmaceuticals and Biotechnology 2020-2025

  • Report
  • September 2025
  • 300 Pages
  • Global
From
Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025 - Product Thumbnail Image

Asset Purchase Deals in Pharmaceuticals and Biotechnology 2019-2025

  • Report
  • September 2025
  • 300 Pages
  • Global
From
From
From
From
Loading Indicator